Abelacimab versus Rivaroxaban in Atrial Fibrillation | NEJM
Quick Take Video Summary from The New England Journal of Medicine — Abelacimab versus Rivaroxaban in Atrial Fibrillation
Quick Take Video Summary from The New England Journal of Medicine — Abelacimab versus Rivaroxaban in Atrial Fibrillation
Beyond ensuring access to gender-affirming surgical care, U.S. carceral facilities can develop health care, housing, and security policies that recognize gender-affirming care as standard practice.
Medicine and Society from The New England Journal of Medicine — Reducing Administrative Harm in Medicine — Clinicians and Administrators Together
Antiviral treatments for respiratory viruses such as respiratory syncytial virus (RSV) are crucial, especially with the rise of the “triple-demic.”
The new indication for semaglutide adds to the long list of conditions that the GLP-1 receptor agonist has been approved for, and provides a new…
Factor VIII gene was introduced into hematopoietic stem cells in men with hemophilia. The annualized bleeding rate went from 10 to 0. No worrisome gene…
Approximately 66% of patients received a COVID-19 vaccine in the fall of 2024 and only 26% received a respiratory syncytial virus vaccine.
The Mental Capacity Act 2005 (MCA) and Gillick judgement,1 taken together, establish clear legal principles to guide consent practices in paediatrics. However, a recent retrospective…
Background Nursing home residents experience a large burden of invasive methicillin-resistant Staphylococcus aureus (MRSA) infections. Data are limited regarding nursing home characteristics associa…
The tension between doctors and physician assistants is a global dilemma and Ghana is no different. Yemisi Bokinni reports “Disappointed chameleons.” That’s how Frank Serebour,…
This cohort study evaluates severe maternal morbidity risk for patients with and without chronic hypertension according to hypertensive disorders developing during pregnancy, unencumbered by preexisting…